Skip to main content

Romina Dieli Crimi

Institutions of which they are part

Senior researcher
Translational Immunology
Vall Hebron Institut de Recerca

Romina Dieli Crimi

Institutions of which they are part

Senior researcher
Translational Immunology
Vall Hebron Institut de Recerca

Projects

Desarrollo de tests rápidos intercambiables para el control multifacético de las infecciones respiratorias

IP: Eva Baldrich Rubio
Collaborators: Romina Dieli Crimi, Cristina Andrés Vergés
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 141875
Reference: PID2023-148950OB-C22
Duration: 01/09/2024 - 31/12/2027

Ministerio de Ciencia

Identification and functional characterization of structural variants in patients with inborn errors of immunity

IP: Roger Colobran Oriol
Collaborators: Romina Dieli Crimi, Aina Aguiló Cucurull, Laura Batlle Masó, Andrea Martín Nalda
Funding agency: Instituto de Salud Carlos III
Funding: 208750
Reference: PI23/00161
Duration: 01/01/2024 - 30/06/2028

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: -
Collaborators: COVID-19, PERFIL INMUNOLÓGICO DE RIESGO, Romina Dieli Crimi, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Arturo Llobell Uriel, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Synthetic diagnostic device to substitute animal erythrocytes in classical haemagglutination assays: application to influenza virus surveillance.

IP: Eva Baldrich Rubio
Collaborators: Romina Dieli Crimi, Mónica Martínez Gallo, Andres Antón Pagarolas, Tomàs Pumarola Suñé, Cristina Andrés Vergés
Funding agency: Instituto de Salud Carlos III
Funding: 104500
Reference: DTS20/00093
Duration: 01/01/2021 - 30/06/2023

Related news

The appointments were announced at the society congress, where seven studies from Vall d’Hebron were also presented.

A Vall d’Hebron team demonstrates, for the first time, the potential of optical genome mapping to detect genetic alterations associated with this rare disease that are not identified using conventional methods.

The study describes the first documented case worldwide of hereditary angioedema transmission through assisted reproduction.

Related professionals

Angel Michael Ortiz Zúñiga

Angel Michael Ortiz Zúñiga

Postdoctoral researcher
Diabetes and Metabolism
Read more
Mar Baz Montero

Mar Baz Montero

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Amaia Latasa Arrazubi

Amaia Latasa Arrazubi

Gestió i Administració
Commercial and Academic Clinical Research
Read more
Ivett Núñez Guzmán

Ivett Núñez Guzmán

Cap d'Unitat
Clinical Trials Economic Evaluation Unit
Commercial and Academic Clinical Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.